Drug Shortage Report for VINORELBINE INJECTION, USP

Last updated on 2018-08-09 History
Report ID 35007
Drug Identification Number 02431130
Brand name VINORELBINE INJECTION, USP
Common or Proper name 10 mg/ml Vinorelbine (as vinorelbine tartrate)
Company Name GENERIC MEDICAL PARTNERS INC
Active Ingredient(s) VINORELBINE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 5ml in clear glass vial
ATC code L01CA
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-12-06
Estimated end date
Actual end date 2018-08-01
Shortage status Resolved
Updated date 2018-08-09
Company comments New batches of 5 ml and 1 ml have been manufactured. Contracted 5 ml demand is now being supplied on allocation. Stock levels are being increased with the manufacture of further batches of both vial sizes.
Health Canada comments
Contact Address 1500 DON MILLS ROAD, SUITE 406
TORONTO, ONTARIO
CANADA M3B 3K4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v30 2018-08-09 French Compare
v29 2018-08-09 English Compare
v28 2018-08-09 English Compare
v27 2018-06-25 French Compare
v26 2018-06-25 English Compare
v25 2018-06-04 French Compare
v24 2018-06-04 English Compare
v23 2018-06-04 English Compare
v22 2018-05-25 French Compare
v21 2018-05-25 English Compare
v20 2018-04-25 French Compare
v19 2018-04-25 English Compare
v18 2018-04-13 French Compare
v17 2018-04-13 English Compare
v16 2018-03-29 French Compare
v15 2018-03-29 English Compare
v14 2018-03-05 French Compare
v13 2018-03-05 English Compare
v12 2018-02-05 French Compare
v11 2018-02-05 English Compare

Showing 1 to 20 of 30